Neurocognition in Hyperinsulinism
Contact
Description
Eligibility and criteria
IRB Number:
22-020300
Eligible age range:
Clinical trial phase:
N/A
Official title:
What to expect
- Visit 1, Initial evaluation: Cognitive assessments and interviews (2 hours)
- Visit 2, Week 52: Cognitive assessments and interviews (2 hours)
- Visit 3, Week 104: Cognitive assessments and interviews (2 hours)
Related specialties
We need families like you
Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.